ClinicalTrials.gg
CompletedNCT04183049Updated Aug 30, 2021

Improved Rehabilitation After Spinal Surgery in Adolescents

An observational study in Pain, Postoperative, Pain and Scoliosis, sponsored by Nantes University Hospital. Completed at 1 site in France. Per ClinicalTrials.gov, last updated 2021-08-30.

Sponsored by Nantes University Hospital · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
30
Sex
All
01

Study summary

Impact of the OFA technique on postoperative recovery from adolescent spine surgery and the incidence of chronic postoperative pain.

Read the detailed description

RACAROFA is an observational, prospective study based on the hypothesis that the OFA technique effectively improves the long-term postoperative rehabilitation of adolescents and reduces the incidence of CPSP. A prospective French multicentre study on this topic is currently not feasible, as other multicentre studies (pain monitoring by the ANI, blood saving strategy) would interfere with potential recruitment.

02

Conditions studied

  • Pain, Postoperative
  • Pain
  • Scoliosis
  • Spinal Fusion

Keywords

  • Dexmedetomidine
  • Analgesics
  • Opioid free anesthesia
  • Chronic postsurgical pain
03

In context

Pain, Postoperative

5,224 studies on the registry are indexed under Pain, Postoperative; 1,154 are open to participants now.

This study's enrollment of 30 is below the median of 100 across 622 observational studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Nantes University Hospital is the lead sponsor of 836 studies on the registry; 196 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

- As the study concerns a specifically paediatric pathology, minors will not be excluded from the study.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patent with idiopathic or secondary surgical scoliosis
  • Management by the paediatric anaesthesia team at the Mother and Child - Hospital of the University Hospital of Nantes
  • Non-opposition to inclusion in the study collected orally from the patient and parents
  • Satisfying oral and written comprehension of the French language, without interpreter
  • Ability to participate in a telephone interview

Exclusion criteria

Exclusion Criteria:

  • Patient that does not understand French correctly
  • Patient unable to express himself/herself correctly in French
  • Patient with a non-scoliotic surgical spinal pathology
  • Refusal to participate in the study
  • Absence of a record of non-opposition to participation in the study from the patient and his or her parents
  • Cerebral palsy or any other condition that does not allow participation in a telephone interview without particular difficulty.
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
30 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Incidence of chronic postsurgical pain after surgery in the adolescent cohort included in the study RACAROFA

    Pain at the surgical site, rated at more than 3 on a numerical scale graduated from 0 (no pain) to 10 (maximum pain) during a telephone interview.

    Time frame: Three months after surgery

  2. Incidence of chronic postsurgical pain after surgery in the adolescent cohort included in the study RACAROFA

    Pain at the surgical site, rated at more than 3 on a numerical scale graduated from 0 (no pain) to 10 (maximum pain) during a telephone interview.

    Time frame: Sixth months after surgery

Secondary outcomes

  1. Occurence of a postoperative opioid-related adverse event

    postoperative hypoxemia or PONV (postoperative nausea and vomiting) or excessive sedation. Postoperative hypoxemia is defined as an oxygen saturation (SpO2) \< 95% with a need for oxygen supplementation within the first 48h after extubation. PONV is defined by use of antiemetics of PONV within the first 48h after extubation. Excessive sedation is defined by a score of 3 in a scale of sedation wich is S1 awake, S2 mild drowsiness, S3 non awakenable.

    Time frame: Within the first 48 hours after extubation

  2. Level of preoperative quality of life

    SRS-30 score (Scoliosis Research Society Health-Related Quality of Life Questionnaire), during a telephone interview. Score between 1 and 5 where 5 is the higher level of quality of live.

    Time frame: Three month after surgery

  3. Postoperative opioid consumption

    Cumulative consumption of opioid in mg/kg.

    Time frame: Within the 2 first weeks postsurgery

  4. Level of preoperative quality of life: SRS-30 score

    SRS-30 score (Scoliosis Research Society Health-Related Quality of Life Questionnaire), during a telephone interview. Score between 1 and 5 where 5 is the higher level of quality of live.

    Time frame: Sixth month after surgery

  5. Postoperative rehabilitation

    Number of days between surgery and first deambulation

    Time frame: Within the first 2 weeks postsurgery

  6. Length of stay in the hospital

    Number of days in the hospital.

    Time frame: Within the first 2 weeks postsurgery

  7. Level of preoperative and postoperative anxiety in the adolescent cohort included in the study RACAROFA

    State trait anxiety Inventory for Children (STAIC) score evaluated during a telephone interview. Score between 20 and 60, where 60 is the higher level of anxiety

    Time frame: Two weeks before surgery

  8. Level of preoperative and postoperative anxiety in the adolescent cohort included in the study RACAROFA

    State trait anxiety Inventory for Children (STAIC) score evaluated during a telephone interview. Score between 20 and 60, where 60 is the higher level of anxiety

    Time frame: three months after surgery

  9. Level of preoperative and postoperative anxiety in the adolescent cohort included in the study RACAROFA

    State trait anxiety Inventory for Children (STAIC) score evaluated during a telephone interview. Score between 20 and 60, where 60 is the higher level of anxiety

    Time frame: sixth months after surgery

  10. Incidence of postoperative neuropathic pain in the adolescent cohort included in the study RACAROFA.

    Modified DN4 score superior at 4.

    Time frame: Three months after surgery

  11. Incidence of postoperative neuropathic pain in the adolescent cohort included in the study RACAROFA.

    Modified DN4 score superior at 4.

    Time frame: Six months after surgery

  12. Postoperative antalgics consumption other than opioid

    Cumulative antalgics consumption other than opioid.

    Time frame: Within the first 2 weeks postsurgery

  13. Incidence of preoperative pain in the adolescent cohort included in the study RACAROFA.

    Back pain, rated at more than 3 on a numerical scale graduated from 0 (no pain) to 10 (maximum pain) during a telephone interview.

    Time frame: Two weeks before surgery

  14. Level of preoperative and postoperative catastrophism in the adolescent cohort included in the study RACAROFA.

    Pain castrophizing scale for adolescent, score evaluated during a telephone interview. Score between 0 and 52, where 52 is the higher level of catastrophism.

    Time frame: Two weeks before surgery, three and sixth months after surgery

  15. Level of preoperative and postoperative catastrophism in the adolescent cohort included in the study RACAROFA.

    Pain castrophizing scale for adolescent, score evaluated during a telephone interview. Score between 0 and 52, where 52 is the higher level of catastrophism.

    Time frame: three months after surgery

  16. Level of preoperative and postoperative catastrophism in the adolescent cohort included in the study RACAROFA.

    Pain castrophizing scale for adolescent, score evaluated during a telephone interview. Score between 0 and 52, where 52 is the higher level of catastrophism.

    Time frame: sixth months after surgery

  17. Level of preoperative and postoperative catastrophism in one of the parents of each adolescent included in the study RACAROFA.

    Pain castrophizing scale for adult, score evaluated during a telephone interview. Score between 0 and 52, where 52 is the higher level of catastrophism.

    Time frame: Two weeks before surgery, three and sixth months after surgery

  18. Level of preoperative and postoperative catastrophism in one of the parents of each adolescent included in the study RACAROFA.

    Pain castrophizing scale for adult, score evaluated during a telephone interview. Score between 0 and 52, where 52 is the higher level of catastrophism.

    Time frame: three months after surgery

  19. Level of preoperative and postoperative catastrophism in one of the parents of each adolescent included in the study RACAROFA.

    Pain castrophizing scale for adult, score evaluated during a telephone interview. Score between 0 and 52, where 52 is the higher level of catastrophism.

    Time frame: sixth months after surgery

  20. Level of preoperative quality of life.

    SRS-22 score (Scoliosis Research Society Health-Related Quality of Life Questionnaire), during a telephone interview. Score between 1 and 5 where 5 is the higher level of quality of live

    Time frame: Two weeks before surgery

07

Study locations

1 site
  • Nantes University Hospital
    Nantes, Loire-Atlantique 44000, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 30, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04183049
Responsible party
Sponsor
First posted
Dec 3, 2019
Start date
Dec 18, 2019
Primary completion
Aug 1, 2021
Completion
Aug 1, 2021
Last update
Aug 30, 2021

Study contacts

Corine LEJUS, PUPH
principal investigator · Nantes University Hospital
Guy LETELLIER, PH
principal investigator · Establishment for Children and Adolescents in the Nantes Region

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion